If CCL25 expression is driven by colitis activity, and colonic CCR9+ T-cells are responsible for driving hepatobiliary inflammation in PSC, then it should follow that the risk of PSC increases with intestinal activity; an observation which does not hold true clinically. Here, CCL25 is linked to colitis.